Kang WK - Search Results

1

Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer.

Kim R, An M, Lee H, Mehta A, Heo YJ, Kim KM, Lee SY, Moon J, Kim ST, Min BH, Kim TJ, Rha SY, Kang WK, Park WY, Klempner SJ, Lee J. Kim R, et al. Among authors: kang wk. Cancer Discov. 2022 Apr 1;12(4):984-1001. doi: 10.1158/2159-8290.CD-21-0888. Cancer Discov. 2022. PMID: 34933901 Free PMC article.

2

Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.

Lee J, Park JO, Kim WS, Lee SI, Song SY, Lim DH, Choi SH, Heo JS, Lee KT, Lee JK, Kim K, Jung CW, Im YH, Lee MH, Kang WK, Park K. Lee J, et al. Among authors: kang wk. Oncology. 2004;66(1):32-7. doi: 10.1159/000076332. Oncology. 2004. PMID: 15031596 Clinical Trial.

3

Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.

Lee J, Park JO, Kim WS, Park SH, Park KW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Joh J, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K. Lee J, et al. Among authors: kang wk. Cancer Chemother Pharmacol. 2004 Nov;54(5):385-90. doi: 10.1007/s00280-004-0837-7. Epub 2004 Jul 10. Cancer Chemother Pharmacol. 2004. PMID: 15248028 Clinical Trial.

4

Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen.

Park SH, Kang WK, Lee HR, Park J, Lee KE, Lee SH, Park JO, Kim K, Kim WS, Chung CW, Im YH, Lee MH, Park CH, Park K. Park SH, et al. Among authors: kang wk. Am J Clin Oncol. 2004 Oct;27(5):477-80. doi: 10.1097/01.coc.0000136018.81814.79. Am J Clin Oncol. 2004. PMID: 15596914 Clinical Trial.

5

Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study.

Lim DH, Park YS, Park BB, Ji SH, Lee J, Park KW, Kang JH, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K. Lim DH, et al. Among authors: kang jh, kang wk. Cancer Chemother Pharmacol. 2005 Jul;56(1):10-4. doi: 10.1007/s00280-004-0963-2. Epub 2005 Mar 22. Cancer Chemother Pharmacol. 2005. PMID: 15782313 Clinical Trial.

6

Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer.

Ji SH, Park YS, Lee J, Lim DH, Park BB, Park KW, Kang JH, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K. Ji SH, et al. Among authors: kang jh, kang wk. Jpn J Clin Oncol. 2005 Apr;35(4):214-7. doi: 10.1093/jjco/hyi061. Jpn J Clin Oncol. 2005. PMID: 15845571 Clinical Trial.

7

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.

Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Ko YH, Ahn YC, Park K. Lee J, et al. Among authors: kang jh, kang wk. Eur J Cancer. 2005 Jul;41(10):1402-8. doi: 10.1016/j.ejca.2005.03.010. Eur J Cancer. 2005. PMID: 15963893

8

Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells.

Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K. Lee J, et al. Among authors: kang wk. Biochem Biophys Res Commun. 2005 Aug 26;334(2):313-8. doi: 10.1016/j.bbrc.2005.06.093. Biochem Biophys Res Commun. 2005. PMID: 16005433

9

Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer.

Park SH, Lee J, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Park YS, Kang WK, Park K, Kim S, Bang SM, Cho EK, Shin DB, Lee JH. Park SH, et al. Among authors: kang wk. Cancer Chemother Pharmacol. 2006 Jan;57(1):91-6. doi: 10.1007/s00280-005-0027-2. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16088407

10

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, Park SH, Lee SH, Kim K, Park JO, Kim WS, Jung CW, Park YS, Im YH, Sohn TS, Noh JH, Heo JS, Kim YI, Park CK, Park K. Kim S, et al. Among authors: kang wk. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1279-85. doi: 10.1016/j.ijrobp.2005.05.005. Epub 2005 Aug 15. Int J Radiat Oncol Biol Phys. 2005. PMID: 16099596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page